ICD-10 Coding for Cervical Intraepithelial Neoplasia II(N87.1)
Complete ICD-10-CM coding and documentation guide for Cervical Intraepithelial Neoplasia II. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Related ICD-10 Code Ranges
Complete code families applicable to Cervical Intraepithelial Neoplasia II
Key Information: ICD-10 code for CIN II
Essential facts and insights about Cervical Intraepithelial Neoplasia II
Primary ICD-10-CM Code for cervical intraepithelial neoplasia ii
Decision Criteria
clinical Criteria
- Biopsy confirms CIN II without HSIL terminology.
coding Criteria
- HSIL terminology requires D06.9.
Applicable To
- Cervical intraepithelial neoplasia [CIN] grade II
Excludes
- Severe dysplasia (CIN III)
- Carcinoma in situ
Clinical Validation Requirements
- Biopsy-confirmed moderate dysplasia
- p16-negative (if tested)
Code-Specific Risks
- Misclassification as CIN III if HSIL is documented
Coding Notes
- Ensure documentation specifies CIN II and p16 status.
Ancillary Codes
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
HPV high-risk positive
R87.610Differential Codes
Alternative codes to consider when ruling out similar conditions to the primary diagnosis.
Carcinoma in situ of cervix uteri
D06.9Documentation & Coding Risks
Avoid these common documentation and coding issues when documenting Cervical Intraepithelial Neoplasia II to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code N87.1.
Impact
Clinical: Lack of specificity in treatment planning, Regulatory: Triggers audits for unspecified codes, Financial: Potential reimbursement issues
Mitigation Strategy
Always specify CIN grade in documentation, Query for clarification if grade is not documented
Impact
Reimbursement: Incorrect DRG assignment, Compliance: Potential audit flags, Data Quality: Inaccurate clinical data
Mitigation Strategy
Verify p16 status and HSIL terminology before coding.
Impact
Risk of misclassification between CIN II and HSIL.
Mitigation Strategy
Verify documentation for p16 status and HSIL terminology.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Frequently Asked Questions
Common questions about ICD-10 coding for Cervical Intraepithelial Neoplasia II, with expert answers to help guide accurate code selection and documentation.
Documentation Templates for Cervical Intraepithelial Neoplasia II
Use these documentation templates to ensure complete and accurate documentation for Cervical Intraepithelial Neoplasia II. These templates include all required elements for proper coding and billing.
Biopsy-confirmed CIN II
Specialty: GynecologyRequired Elements
- Biopsy report
- p16 status
- HPV test results
Example Documentation
Examples: Poor vs. Good Documentation
Poor Documentation Example
Good Documentation Example
Explanation
Need help with ICD-10 coding for Cervical Intraepithelial Neoplasia II? Ask your questions below.